Lurasidone as a potential therapy for bipolar disorder
Young Sup Woo, Hee Ryung Wang, Won-Myong Bahk Department of Psychiatry, Yeouido St Mary's Hospital, The Catholic University of Korea, Seoul, Korea Abstract: Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute t...
Main Authors: | Woo YS, Wang HR, Bahk WM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/lurasidone-as-a-potential-therapy-for-bipolar-disorder-a14612 |
Similar Items
-
Lurasidone for the treatment of bipolar depression: an evidence-based review
by: Franklin R, et al.
Published: (2015-08-01) -
Lurasidone for the treatment of bipolar depression: an evidence-based review
by: Deckersbach, Thilo, et al.
Published: (2015) -
Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
by: Wang HR, et al.
Published: (2015-03-01) -
Lurasidone hydrochloride
by: Huijuan Jiang, et al.
Published: (2012-05-01) -
Clinical potential of lurasidone in the management of schizophrenia
by: Samalin L, et al.
Published: (2011-06-01)